A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin And Skin Structure Infections

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-002301-23

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate the noninferiority of ceftobiprole/placebo compared with Vancomycin/ceftazidime with respect to clinical cure rate in subjects with complicated skin and skin structure infections (cSSSI) at the test-of-cure (TOC) visit


Critère d'inclusion

  • COMPLICATED SKIN AND SKIN STRUCTURE INFECTION